Review Article Open Access

Application of Artificial Intelligence in Pharmaceutical Sectors

Abstract

Here, the application of Artificial Intelligence (AI) in the pharmaceutical sectors was reviewed critically, with an emphasis on the transformative power of AI across multiple domains. The review examined how artificial intelligence is used in clinical trials, manufacturing, drug discovery, personalized medicine, and regulatory compliance. AI accelerated target identification and predictive analytics in drug discovery, improved patient recruitment and trial monitoring, and streamlined manufacturing processes. Personalized medicine was further enhanced by AI-driven biomarker discovery, and compliance was guaranteed by automated regulatory monitoring. Interoperability problems and data privacy remained obstacles despite progress. To overcome these obstacles, cooperation and standardization measures were needed. All things considered, the adoption of AI in the pharmaceutical industry represented a paradigm shift in favor of efficiency and innovation.

Balisa Mosisa Ejeta*, Malay K Das, Sanjoy Das, Fetene Fufa Bakare, Hawi Nigussie

To read the full article Download Full Article